<!doctype html><html lang=en><meta charset=utf-8><meta name=generator content="Hugo 0.78.1"><meta name=viewport content="width=device-width,initial-scale=1,viewport-fit=cover"><meta name=color-scheme content="light dark"><meta name=supported-color-schemes content="light dark"><title>Lancaster 2016&nbsp;&ndash;&nbsp;Papers</title><link rel=stylesheet href=/stevengogogo/PaperNotes/css/core.min.0e6154f1fe5441faaa4f418ca1a607b9f3edbad43b1ab8782737ee279ca2c5a48c8dbe23af3340af50c91a2558bc2b55.css integrity=sha384-DmFU8f5UQfqqT0GMoaYHufPtutQ7Grh4JzfuJ5yixaSMjb4jrzNAr1DJGiVYvCtV><meta name=twitter:card content="summary"><meta name=twitter:title content="Lancaster 2016"><body><section id=header><div class="header wrap"><span class="header left-side"><a class="site home" href=/stevengogogo/PaperNotes/><span class="site name">Papers</span></a></span>
<span class="header right-side"><div class="nav wrap"><nav class=nav><a class="nav item" href=/stevengogogo/PaperNotes/categories/>Categories</a><a class="nav item" href=/stevengogogo/PaperNotes/tags/>Tags</a></nav></div></span></div><div class="site slogan"><span class=title>Collection of papers I read</span></div></section><section id=content><div class=article-container><section class="article header"><h1 class="article title">Lancaster 2016</h1><p class="article date">2020-10-23</p></section><article class="article markdown-body"><p><a href=https://sciwheel.com/work/#/items/5876765 target=_blank>Sciwheel</a></p><p><a href=https://ascpt.onlinelibrary.wiley.com/doi/full/10.1002/cpt.367 target=_blank>Article</a><sup id=fnref:1><a href=#fn:1 class=footnote-ref role=doc-noteref>1</a></sup></p><h2 id=introduction>Introduction</h2><ul><li>drug‐induced Torsades de Pointes (TdP) remains a critical issue in drug development.<ul><li>blockade of the KCNH2, or hERG (IKr)</li></ul></li><li>Reduction in IKr increases the action potential duration (APD), which appears as an increased QT interval in the EKG</li><li>A major shortcoming of the hERG assay is the failure to account for <em>multichannel</em> drug effects.</li><li>The goal of this study was twofold<ol><li>to develop a classifier for improved prediction of drug torsadogenicity.</li><li>apply our classifier to identify key cellular physiological differences between torsadogenic and nontorsadogenic drugs</li></ol></li><li>Quantitative Systems Pharmacology approach : combined modeling of <em>physiological dynamics</em> with <em>statistical analysis and machine‐learning</em></li></ul><h2 id=results>RESULTS</h2><h3 id=human-ventricular-cell-models-simulate-drug-response>Human ventricular cell models simulate drug response</h3><p><img src=https://user-images.githubusercontent.com/40054455/86700407-add54b00-c043-11ea-9fef-64213bfa14fc.jpg alt=fig1></p><ul><li>simulated the application of 86 drugs at effective free therapeutic plasma concentration (EFTPC) in three recent, independently formulated human ventricular myocyte models (TP, GPB, ORd)</li><li>13 metrics in the AP and Ca trasient curves</li></ul><h3 id=a-novel-classification-method-identifies-torsadogenic-drugs>A novel classification method identifies torsadogenic drugs</h3><p><img src=https://user-images.githubusercontent.com/40054455/86700411-af067800-c043-11ea-9848-ae91d835637d.jpg alt=fig2>
<img src=https://user-images.githubusercontent.com/40054455/86700453-b6c61c80-c043-11ea-8ef5-074d150429e1.png alt=tbl1></p><ul><li><strong>principal components</strong> (PCs) from the metrics: first three PCs describe 88.2% of the variance</li><li>clear division between torsadogenic and nontorsadogenic drugs</li><li>The drug scores in the PC space were used to train a <strong>support vector machine (SVM) classifier</strong>, with accuarcy of 87.2%. Area under ROC curve (auROC) was 0.963.</li><li>substantial improvement over classifications based on either hERG block or APD at 90% repolarization (APD90)</li></ul><h3 id=ca2-dynamics-augment-action-potential-duration-to-identify-torsadogenic-drugs>Ca2+ dynamics augment action potential duration to identify torsadogenic drugs</h3><p><img src=https://user-images.githubusercontent.com/40054455/86700418-af9f0e80-c043-11ea-8175-3bb6b16546fe.jpg alt=fig3></p><ul><li>PC scores are less clear in mechanisms explanation</li><li>Classification based on <strong>specific simulated metrics</strong> rather than PC scores provides <em>physiological insight</em> into differences between drugs</li><li>two to three metrics may allow for accurate drug classification (from PC analysis)</li><li>APD at 50% repolarization (APD50) and diastolic (Ca2+)i => auROC = 0.962</li><li>drugs with dramatic AP prolongation are torsadogenic. diastolic (Ca2+)i provides the additional information necessary to classify the drugs.</li></ul><h3 id=risk-prediction-is-robust-across-a-large-range-of-doses>Risk prediction is robust across a large range of doses</h3><p><img src=https://user-images.githubusercontent.com/40054455/86700424-b0d03b80-c043-11ea-8756-210b42dbd2b8.jpg alt=fig4></p><ul><li>repeated the classification analysis after simulating each drug at 0.1, 1, 10, and 100 times typical clinical concentration (EFTPC)</li><li>dose‐dependence of each drug&rsquo;s distance from the decision boundary</li><li>Amiodarone, imipramine, and solifenacin were close to the origin at EFTPC, but higher concentrations of these drugs moved them onto the correct, torsadogenic side of the decision boundary.</li><li>The classification algorithm correctly predicted the torsadogenicity of donepezil, previously regarded safe.</li></ul><h3 id=a-synthetic-population-stratifies-drug-risk>A synthetic population stratifies drug risk</h3><p><img src=https://user-images.githubusercontent.com/40054455/86700439-b3329580-c043-11ea-9c79-be9e774bfdfb.jpg alt=fig5></p><ul><li>generated a synthetic population of 24 individuals by randomly varying ionic current parameters and calibrating the population variability to experimental data</li><li>Simulating drug effects in a synthetic population allows us to compute probabilities of TdP risk</li><li>Ibutilide, a class III antiarrhythmic with a well‐established risk of Torsades, is predicted to be dangerous in the majority (71%) of individuals</li><li>nitrendipine is a dihydropyridine Ca2+‐channel blocker with no known risk of Torsades that is predicted to be safe in all individuals in the population</li><li>nilotinib: safe in the majority of individuals, but torsadogenic in a subset (12.5%).</li></ul><h3 id=offtarget-interactions-influence-drug-risk>Off‐target interactions influence drug risk</h3><p><img src=https://user-images.githubusercontent.com/40054455/86700447-b463c280-c043-11ea-95a0-7fb6452f1a98.jpg alt=fig6></p><ul><li>we generated 100 hypothetical drugs that alter the activity of nine ion channels, pumps and transporters distinct from those targeted by the original drug set.</li><li>predict the influence of each parameter on drug risk</li><li>alterations to the <strong>Na+‐Ca2+ exchanger</strong> have the largest effect on TdP risk, with increased current leading to decreased risk. The Na+‐K+ ATPase, background Ca2+ current and the SERCA pump followed in significance</li><li>increases in the activity of the Na+‐K+ ATPase and the Na+‐Ca2+ exchanger were protective, whereas decreases were predicted to be torsadogenic</li><li>slow delayed rectifier (GKs) and the inward rectifier (GK1): blocking either K+ current is predicted to be torsadogenic, and enhancing either is protective</li></ul><h2 id=discussion>DISCUSSION</h2><ul><li>Quantitative Systems Pharmacology (QSP) strategy, running extensive mechanistic simulations based on results from a large drug dataset.</li><li>provide deeper insight into the physiological mechanisms of drug action than the “snapshot” one obtains using high‐throughput measurements, such as ion channel block or altered gene expression</li><li>the value of simulations to not only predict cellular drug responses, but to <strong>direct experimental studies</strong></li><li>we do not assume the primacy of particular physiological responses, such as AP prolongation. Instead, we calculate from simulations a <em>wide range of metrics</em>, and then systematically determine which are most informative</li><li>drug‐induced changes in <strong>diastolic (Ca2+)</strong> were nearly as important as changes in <strong>APD</strong> to differentiate between torsadogenic and nontorsadogenic drugs</li><li>Na+‐K+ ATPase, Na+‐Ca2+ exchanger, background Ca2+ current, and the SERCA pump as the most significant potential modulators of TdP risk</li><li>peak INa inhibition does not account for specific effects on the late Na+ current (INaL)</li><li>Our method also does not include drug effects on channel trafficking, which plays a role in the torsadogenesis of some drugs</li></ul><h2 id=methods>METHODS</h2><h3 id=models-and-simulations>Models and simulations</h3><ul><li>(1) OVVR14; (2) ten Tusscher and Panfilov12; and (3) Grandi, Pasqualini, and Bers</li><li>stimulated at rates of 2 Hz, 1 Hz, and 0.5 Hz to steady state</li><li>under 24 different conditions: at 3 pacing rates × 8 cell types</li></ul><h3 id=databases>Databases</h3><ul><li>reported half‐maximal inhibitory concentrations (IC50) for channel inhibition. We obtained these data for 86 drugs published in the studies by Kramer et al. and Mirams et al. as training set.</li><li>We defined the torsadogenicity of the drugs in our training set using the CredibleMeds database (<a href=https://www.crediblemeds.org>https://www.crediblemeds.org</a>)</li></ul><h3 id=classification-of-drugs>Classification of drugs</h3><ul><li>331 metrics => PCs => training a SVM classifier15 with a linear kernel</li></ul><h2 id=reference>Reference</h2><section class=footnotes role=doc-endnotes><hr><ol><li id=fn:1 role=doc-endnote><p>Lancaster MC, Sobie EA. Improved Prediction of Drug-Induced Torsades de Pointes Through Simulations of Dynamics and Machine Learning Algorithms. Clin. Pharmacol. Ther. 2016;100(4):371-379. doi:10.1002/cpt.367. <a href=https://ascpt.onlinelibrary.wiley.com/doi/full/10.1002/cpt.367 target=_blank>ASCPT</a> <a href=#fnref:1 class=footnote-backref role=doc-backlink>&#8617;&#xfe0e;</a></p></li></ol></section></article><section class="article author"><p class=name>Shao-Ting Chiu</p><div class=details><a class=item href=https://github.com/stevengogogo target=_blank><span class="iconfont icon-github"></span>&nbsp;stevengogogo</a></div></section></div><div class="article bottom"><section class="article navigation"><p><a class=link href=/stevengogogo/PaperNotes/posts/lebrecht-2003/><span class="iconfont icon-article"></span>Lebrecht 2003</a></p><p><a class=link href=/stevengogogo/PaperNotes/posts/krab-2011/><span class="iconfont icon-article"></span>Krab 2011</a></p></section></div></section><section id=footer><div class=footer-wrap><p class=copyright>Papers</p><p class=powerby><span>Powered&nbsp;by&nbsp;</span><a href=https://gohugo.io target=_blank>Hugo</a><span>&nbsp;&&nbsp;</span><a href=https://themes.gohugo.io/hugo-notepadium/ target=_blank>Notepadium</a></p></div></section><link rel=stylesheet href=https://cdn.jsdelivr.net/npm/katex@0.11.1/dist/katex.min.css integrity=sha384-zB1R0rpPzHqg7Kpt0Aljp8JPLqbXI3bhnPWROx27a9N0Ll6ZP/+DiW/UqRcLbRjq crossorigin=anonymous><script defer src=https://cdn.jsdelivr.net/npm/katex@0.11.1/dist/katex.min.js integrity=sha384-y23I5Q6l+B6vatafAwxRu/0oK/79VlbSz7Q9aiSZUvyWYIYsd+qj+o24G5ZU2zJz crossorigin=anonymous></script><script defer src=https://cdn.jsdelivr.net/npm/katex@0.11.1/dist/contrib/auto-render.min.js integrity=sha384-kWPLUVMOks5AQFrykwIup5lo0m3iMkkHrD0uJ4H5cjeGihAutqP0yW0J6dpFiVkI crossorigin=anonymous onload=renderMathInElement(document.body);></script></body></html>